Immunicum AB's market cap is currently kr310.94M. The company's EPS TTM is kr-0.45; its P/E ratio is ―; Immunicum AB is scheduled to report earnings on August 21, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
